SCHEMBL1844189

SCHEMBL1844189

O=C(CCc1ccc(O)c(O)c1)c1c(O)cc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 1.00
TYR P14679 1/20 1.00
SLC5A1 P13866 7/20 0.75
SLC5A2 P31639 7/20 0.75
GAA P10253 2/20 0.75
MAPT P10636 2/20 0.75
NFKB1 P19838 2/20 0.75
NFKB2 Q00653 2/20 0.75
RELA Q04206 2/20 0.75
KDM4E B2RXH2 1/20 0.75
MEN1 O00255 1/20 0.75
SLC16A3 O15427 1/20 0.75
ALDH1A1 P00352 1/20 0.75
LMNA P02545 1/20 0.75
TTR P02766 1/20 0.75
ESR1 P03372 1/20 0.75
TP53 P04637 1/20 0.75
CYP1A2 P05177 1/20 0.75
POLB P06746 1/20 0.75
CYP3A4 P08684 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29716655 1.00 CYP19A1 (1.00) CYP19A1TYRSLC5A1SLC5A2GAA
SCHEMBL15457887 0.87 NFKB1 (0.78) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL38131 0.86 SLC5A1 (1.00) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL1506325 0.86 SLC5A1 (1.00) CYP19A1TYRSLC5A1SLC5A2GAA
SCHEMBL31450931 0.85 CYP19A1 (0.74) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL30912872 0.84 SLC5A1 (0.96) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL30785809 0.84 SLC5A1 (0.96) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL31684375 0.84 SLC5A1 (0.96) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL21192491 0.83 SLC5A1 (0.87) CYP19A1TYRSLC5A1SLC5A2GAA
Phloretin SCHEMBL27910960 0.83 SLC5A1 (0.93) CYP19A1TYRSLC5A1SLC5A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1972203-B1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste SYMRISE AG (DE) 2012-05-16 EP claimed
EP-1977655-B1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions SYMRISE AG (DE) 2011-05-18 EP claimed
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2010-09-16 US claimed
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP claimed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP claimed
EP-1977655-A1 Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions Symrise GmbH & Co. KG (DE) 2008-10-08 EP claimed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US claimed
EP-1972203-A1 Use of 4-hydroxychalkon derivatives for masking an unpleasant taste Symrise GmbH & Co. KG (DE) 2008-09-24 EP claimed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US claimed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO claimed
EP-0292576-A1 ANTI-ULCEROUS AGENT CONTAINING CHALCONE DERIVATIVE AS EFFECTIVE INGREDIENT AND NOVEL CHALCONE DERIVATIVES TSUMURA & CO. (JP) 1988-11-30 EP claimed
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF FIRMENICH INCORPORATED (US) 2025-03-13 US disclosed
WO-2023278394-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF FIRMENICH INCORPORATED (US) 2023-01-05 WO disclosed
EP-2692729-B1 Method for the biotechnological manufacture of dihydrochalcones SYMRISE AG (DE) 2016-12-07 EP disclosed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed
US-5234951-A Anti-ulcer agent comprising chalcone derivative TSUMURA JUNTENDO, INC. (JP) 1993-08-10 US disclosed
US-5106871-A Reduced side effects TSUMURA & CO. (JP) 1992-04-21 US disclosed
EP-0292576-A1 ANTI-ULCEROUS AGENT CONTAINING CHALCONE DERIVATIVE AS EFFECTIVE INGREDIENT AND NOVEL CHALCONE DERIVATIVES TSUMURA & CO. (JP) 1988-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084049-A1 POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF PGC, SLC5A6, PUF60 CYP19A1 4434/4885TYR 341/4885SLC5A1 207/4885
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 CYP19A1 4132/4885TYR 4586/4885SLC5A1 1320/4885
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS TAS2R5, TAS2R20, TAS2R40 CYP19A1 1036/4885TYR 95/4885SLC5A1 1754/4885
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS TAS2R4, TAS2R1, TAS2R20 CYP19A1 2966/4885TYR 2707/4885SLC5A1 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.